Endogenous Metabolite (EM) Information
| Endogenous Metabolite (EM) Information | ||||||
|---|---|---|---|---|---|---|
| EM ID |
EM00177
|
|||||
| EM Name |
Succinyladenosine
|
|||||
| Synonyms |
Succinyladenosine; Succinoadenosine; (S)-N-(1,2-dicarboxyethyl)-Adenosine; N-9-ribofuranosyl-9H-purin-6-yl-Aspartic acid; ZINC12494556; N-9-ribofuranosyl-9H-purin-6-yl-Aspartate; N-(9-b-D-ribofuranosyl-9H-purin-6-yl)-L-Aspartate; N-(9-b-D-ribofuranosyl-9H-purin-6-yl)-L-Aspartic acid; 6-(1,2-Dicarboxyethylamino)-9-b-D-ribofuranosylpurine; N-(9-beta-delta-ribofuranosyl-9H-purin-6-yl)-L-Aspartate; 6-(1,2-Dicarboxyethylamino)-9-beta-D-ribofuranosylpurine
|
|||||
| Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=20849086"></iframe>
|
![]() |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C14H17N5O8
|
|||||
| Canonical SMILES |
C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)NC(CC(=O)O)C(=O)O
|
|||||
| InChI |
InChI=1S/C14H17N5O8/c20-2-6-9(23)10(24)13(27-6)19-4-17-8-11(15-3-16-12(8)19)18-5(14(25)26)1-7(21)22/h3-6,9-10,13,20,23-24H,1-2H2,(H,21,22)(H,25,26)(H,15,16,18)/t5-,6+,9+,10+,13+/m0/s1
|
|||||
| InChIKey |
VKGZCEJTCKHMRL-VWJPMABRSA-N
|
|||||
| CAS Number |
CAS 4542-23-8
|
|||||
| Pharmaceutical Properties | Molecular Weight | 383.31 | Topological Polar Surface Area | 200 | ||
| Heavy Atom Count | 27 | Rotatable Bond Count | 7 | |||
| Hydrogen Bond Donor Count | 6 | Hydrogen Bond Acceptor Count | 12 | |||
| XLogP |
-0.7
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:71169
|
|||||
| DT(s) "handling" This EM | MRP6 | Transporter Info | Multidrug resistance-associated protein 6 | [1] | ||
| References | ||||||
| 1 | Untargeted Metabolomics Analysis of ABCC6-Deficient Mice Discloses an Altered Metabolic Liver Profile. J Proteome Res. 2016 Dec 2;15(12):4591-4600. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
